FPCP
GILD icon

Fort Point Capital Partners’s Gilead Sciences GILD Stock Holding History

Fort Point Capital Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$463K Buy
3,320
+110
+3% +$15.4K 0.06% 148
2025
Q4 		$389K Hold
3,210
– – 0.04% 167
2025
Q3 		$356K Sell
3,210
-8,153
-72% -$927K 0.04% 173
2025
Q2 		$1.26M Buy
11,363
+8,004
+238% +$852K 0.09% 129
2025
Q1 		$376K Sell
3,359
-1,848
-35% -$191K 0.04% 239
2024
Q4 		$481K Sell
5,207
-126
-2% -$11.3K 0.05% 211
2024
Q3 		$447K Buy
5,333
+146
+3% +$11.1K 0.06% 197
2024
Q2 		$356K Sell
5,187
-174
-3% -$11.6K 0.05% 231
2024
Q1 		$393K Buy
5,361
+16
+0.3% +$1.23K 0.05% 219
2023
Q4 		$433K Sell
5,345
-200
-4% -$15.6K 0.06% 193
2023
Q3 		$416K Buy
5,545
+16
+0.3% +$1.23K 0.06% 163
2023
Q2 		$426K Buy
5,529
+87
+2% +$6.94K 0.06% 174
2023
Q1 		$452K Buy
5,442
+152
+3% +$12.6K 0.07% 169
2022
Q4 		$454K Buy
5,290
+90
+2% +$7.13K 0.07% 160
2022
Q3 		$321K Buy
5,200
+18
+0.3% +$1.14K 0.05% 196
2022
Q2 		$320K Sell
5,182
-7,985
-61% -$494K 0.05% 214
2022
Q1 		$783K Buy
13,167
+8,022
+156% +$513K 0.11% 127
2021
Q4 		$374K Buy
5,145
+15
+0.3% +$1.03K 0.05% 203
2021
Q3 		$358K Buy
5,130
+1,650
+47% +$116K 0.05% 175
2021
Q2 		$240K Hold
3,480
– – 0.04% 148
2021
Q1 		$225K Buy
+3,480
New +$224K 0.05% 141
2020
Q3 		– Sell
-3,000
Closed -$231K – 147
2020
Q2 		$231K Buy
+3,000
New +$230K 0.07% 116
2020
Q1 		– Sell
-10,000
Closed -$650K – 120
2019
Q4 		$650K Buy
10,000
+4,241
+74% +$276K 0.23% 54
2019
Q3 		$365K Buy
+5,759
New +$376K 0.14% 80
2015
Q3 		– Sell
-9,502
Closed -$1.12M – 89
2015
Q2 		$1.12M Buy
9,502
+478
+5% +$52.2K 0.7% 27
2015
Q1 		$886K Sell
9,024
-180
-2% -$18.3K 0.58% 26
2014
Q4 		$868K Buy
+9,204
New +$952K 0.65% 25

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fort Point Capital Partners's GILD Position: Q1 2026 in Review

Fort Point Capital Partners increased its Gilead Sciences (GILD) stake by 3.4% in Q1 2026, buying an estimated $15.4K and bringing the position to 3,320 shares worth $463K. The position accounts for 0.06% of the portfolio, ranked #148.

Fort Point Capital Partners first reported a position in GILD in Q4 2014 and has held it in 27 quarters since. The position peaked at $1.26M in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Fort Point Capital Partners held 3,320 shares of Gilead Sciences worth $463K as of Q1 2026.
  • Fort Point Capital Partners bought 110 Gilead Sciences shares in Q1 2026, an estimated $15.4K.
  • Gilead Sciences made up 0.06% of Fort Point Capital Partners's portfolio in Q1 2026, its #148 holding.
  • Fort Point Capital Partners first reported a position in Gilead Sciences in Q4 2014 and has held it in 27 quarters since.
  • Fort Point Capital Partners's Gilead Sciences position peaked at $1.26M in Q2 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Fort Point Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.